Valuation: Incyte Corporation

Capitalization 1.91TCr 1.65TCr 1.51TCr 1.43TCr 2.63TCr 1,84900Cr 2.69TCr 18TCr 7TCr 87TCr 7.17TCr 7.01TCr 3,04000Cr P/E ratio 2026 *
14.5x
P/E ratio 2027 * 12.6x
Enterprise value 1.41TCr 1.21TCr 1.11TCr 1.05TCr 1.94TCr 1,36100Cr 1.98TCr 13TCr 5.16TCr 64TCr 5.28TCr 5.16TCr 2,23800Cr EV / Sales 2026 *
2.5x
EV / Sales 2027 * 1.98x
Free-Float
98.1%
Yield 2026 *
-
Yield 2027 * -
1 day+0.43%
1 week-3.56%
Current month+0.35%
1 month-2.27%
3 months-6.03%
6 months-5.65%
Current year-3.21%
1 week 94.1
Extreme 94.1
99.36
1 month 92.79
Extreme 92.79
103.01
Current year 89.25
Extreme 89.25
112.29
1 year 63.51
Extreme 63.51
112.29
3 years 50.27
Extreme 50.27
112.29
5 years 50.27
Extreme 50.27
112.29
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Change 5d. change 1-year change 3-years change Capi.($)
+0.43%-3.56%+49.82%+50.39% 1.91TCr
+0.10%-12.87%+5.66%-16.96% 6.41TCr
+0.17%-1.63%+46.00%+169.42% 5.18TCr
-2.89%+34.60%+34.60%+34.60% 4.13TCr
-0.22%-0.32%-59.65%-67.95% 3.39TCr
-0.70%-4.41%+47.22%-38.23% 2.81TCr
-4.97%-14.17%+73.25%-63.78% 1.81TCr
-1.00%-8.96%+43.31%+103.99% 1.77TCr
-0.85%-1.55%+39.11%+80.82% 1.6TCr
+1.04%+0.08%+95.90%+381.05% 1.29TCr
Average -0.89%-5.29%+37.52%+63.33% 3.03TCr
Weighted average by Cap. -0.77%-5.89%+27.68%+44.88%

Financials

2026 *2027 *
Net sales 562.17Cr 484.87Cr 444.16Cr 419.7Cr 773.74Cr 54TCr 793.22Cr 5.29TCr 2.06TCr 26TCr 2.11TCr 2.06TCr 89TCr 622.87Cr 537.22Cr 492.12Cr 465.02Cr 857.29Cr 60TCr 878.86Cr 5.86TCr 2.28TCr 28TCr 2.34TCr 2.29TCr 99TCr
Net income 137.69Cr 118.75Cr 108.78Cr 102.79Cr 189.51Cr 13TCr 194.28Cr 1.3TCr 504.86Cr 6.28TCr 516.68Cr 505.67Cr 22TCr 159.85Cr 137.87Cr 126.29Cr 119.34Cr 220Cr 15TCr 225.54Cr 1.51TCr 586.11Cr 7.29TCr 599.84Cr 587.05Cr 25TCr
Net Debt -503.83Cr -434.55Cr -398.07Cr -376.15Cr -693.45Cr -49TCr -710.9Cr -4.74TCr -1.85TCr -23TCr -1.89TCr -1.85TCr -80TCr -679.18Cr -585.79Cr -536.61Cr -507.06Cr -934.8Cr -66TCr -958.32Cr -6.39TCr -2.49TCr -31TCr -2.55TCr -2.49TCr -1,08100Cr
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
19/26/19 95.60 $ +0.43% 11,66,723
18/26/18 95.19 $ -0.13% 10,20,910
15/26/15 95.31 $ -2.38% 16,48,990
14/26/14 97.63 $ -1.20% 13,50,211
13/26/13 98.82 $ -0.31% 16,30,417
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
95.60USD
Average target price
108.50USD
Spread / Average Target
+13.49%

Quarterly revenue - Rate of surprise